Se espera que el mercado de la proteómica crezca a una tasa anual compuesta del 15,15 % entre 2023 y 2029. Se espera que alcance más de 74 270 millones de dólares en 2029 desde los 21 790 millones de dólares en 2022.
Un proteoma es el conjunto completo de proteínas que genera un sistema u organismo. Puede cambiar dependiendo del tiempo, las especificaciones y las tensiones a las que se somete un organismo. La proteómica se define como la rama de la biotecnología que se ocupa de utilizar la biología molecular, la bioquímica y las técnicas genéticas para examinar la estructura, la función y las interacciones de las proteínas producidas por los genes de una célula, tejido u organismo específico, tratando de organizar la información en bases de datos y aplicando los datos (como en medicina o biología). La investigación proteómica es el estudio sistemático a gran escala de las proteínas. Debido a que las proteínas son los componentes básicos de las células, la investigación proteómica busca responder todas las preguntas sobre ellas.
La investigación en proteómica puede beneficiarse de los avances en espectrometría de masas y bases de datos de secuencias de proteínas y ADN. Para la identificación de proteínas, la determinación cuantitativa y el reconocimiento de interacciones proteínicas, la proteómica requiere un conjunto diverso de instrumentos, maquinaria, reactivos, medios y software. Algunos de los tipos más comunes de proteómica se clasifican como proteómica estructural, proteómica de expresión y proteómica funcional. La cristalografía de rayos X y la espectroscopia de resonancia magnética nuclear son dos tecnologías utilizadas en la proteómica estructural. En la proteómica de expresión, se utilizan tecnologías como la electroforesis en gel de poliacrilamida 2D y la espectrometría de masas, mientras que la cromatografía de afinidad se implementa para aislar subproteomas.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por producto, por tecnología, por aplicación, por usuario final, por región |
| Por tecnología de resina |
|
| Por tecnología |
|
| Por aplicación |
|
| Por el usuario final |
|
| Por región |
|
El brote de COVID-19 ha obstaculizado las operaciones en la industria de la salud a nivel mundial. La enfermedad ha obligado temporalmente a varios sectores, incluidos algunos de la industria de la salud, a cerrar sus puertas. La pandemia aumentó considerablemente la demanda de servicios de proteómica en 2020, lo que provocó un crecimiento modesto en el mercado mundial de la proteómica.
Además, la identificación de proteínas específicas de COVID-19 fue posible gracias a la aplicación de métodos de espectrómetro de masas de vanguardia. Sin embargo, se prevé que el mercado de la proteómica aumente de manera constante en 2021 y se expanda a una CAGR considerable durante el transcurso del período de pronóstico. Esto se explica por el aumento en el uso de medicamentos personalizados para el tratamiento de enfermedades específicas durante COVID-19, así como por un aumento en la innovación tecnológica en el campo de la proteómica.
The Proteomics Market size had crossed USD 21.79 Billion in 2020 and will observe a CAGR of more than 15.15% up to 2029.
Major factors driving the proteomics market growth include the rise in the geriatric population demanding personalized medicines, growing demand for advanced diagnostics in targeted disease treatment, growing prevalence of target diseases, growing demand for therapeutic medicines, and outbreak of COVID-19.
Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, GE Healthcare, Luminex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Creative Proteomics, Promega Corporation, Sengenics, Danaher Corporation, Horiba Ltd. are the major Proteomics market players.
The region's largest share is in North America. Products manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
The proteomics market is segmented based on products, technology, application, end user, and region, global trends and forecast.
On the basis of products, the market is segmented into instruments, reagents & kits, core proteomics services.
The worldwide proteomics market is divided into services, reagents & kits, and instruments based on product. In 2021, more than 70% of global revenue came from the reagents and kits market. The segment is anticipated to increase at the fastest rate throughout the course of the projection period. This is because academic institutions, research labs, and other institutions frequently employ reagents, kits, chemicals, and strips for the inspection of diverse biological samples, which will enhance demand for reagents & kits and support sector growth. Proteomics market expansion would also be supported by technological developments in sophisticated tools, such as 2-d electrophoresis protein analyzers, that increase the productivity, throughput, and speed of biological research.
On the basis of technology, the market is segmented into microarray instruments, x-ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis, surface plasma resonance systems.
The segment with the largest income share in 2021—more than 47.00%—was spectroscopy. During the forecast period, it is anticipated to increase at the fastest rate going forward. The widespread use of spectroscopy-based technologies in numerous analytical applications, such as drug development procedures, proteomics, metabolomics, forensic analysis, and pharmaceutical analysis, is one of the key reasons fueling the segment's expansion.
On the basis of application, the market is segmented into drug discovery, clinical diagnosis, cancer research.
In 2021, the clinical diagnostics segment held a share of more than 51.65%, dominating the market. This is explained by the widespread use of protein analysis in clinical research to find illness biomarkers for early disease identification and to pinpoint specific risk factors. It is anticipated that this would open up new avenues for illness prevention and early intervention. Proteomics-based diagnostics makes it feasible to find prospective biomarkers and protein expression patterns that might be used to identify, forecast, and assess the prognosis of malignancies, which supports the segment's expansion.
On the other hand, it is predicted that during the projected time, the drug discovery segment will increase at the fastest rate. The expansion of this market can be attributed to the development of structure-based drug design, increased emphasis on developing specially chosen, and increased funding in these fields. Proteomics technologies also provide a mechanism to demonstrate a medicine's potential early in the drug discovery process, saving pharmaceutical companies a large sum of money and ultimately helping patients and healthcare systems, which supports the segment's expansion.
On the basis of end user, the market is segmented into contract research organizations, research & academic institutes, pharma & biotech companies.
By the ending of 2023, the research and academic institutions sector is anticipated to have a bigger market share of around 51.5%. An increase in research and development activities, a diversity of ongoing proteome studies for the treatment of various life-threatening diseases, and an increase in life science projects in research and academic settings are all contributing to the increased demand for molecular biology, enzymes, reagents, and kits.
[caption id="attachment_15083" align="aligncenter" width="1920"]
Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, GE Healthcare, Luminex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Creative Proteomics, Promega Corporation, Sengenics, Danaher Corporation, Horiba Ltd. are the major Proteomics market players.
6 February, 2023: Thermo Fisher Scientific announced its collaboration with Celltrio to bring a fully automated cell system to biotherapeutics customers. Thermo Fisher will take on responsibility for sales, installation and support in Europe.
22 December, 2022: Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., to discover novel antibody-drug conjugates leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform.
The Proteomics Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
With a 45.90% revenue share in 2021, North America dominated the sector. The development of structure-based drug design, development of omics research, desire for high-quality research tools for data reproducibility, and focus on the creation of customized treatments are all attributed with this. Partnerships and cooperation among leading businesses in this area are also helping to expand this sector.
Due to increased outsourcing of proteomics-based projects, public and private funding for research and development for proteomics studies, advantageous government regulations, rising prevalence of target diseases with an older workforce, and rising proteomics adoption, the Asia Pacific region is predicted to grow at the fastest CAGR between 2022 and 2030. For instance, the Department of Biotechnology of the Indian tax payer funded 60 million dollars to the University of Hyderabad in November 2021 to study the tomato proteome. Such government initiatives to promote the proteomics study are driving the market in Asia Pacific.
[caption id="attachment_15090" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.